The response to IV rt-PA in very old stroke patients

European Journal of Neurology

Volumn 15, Issue 3, 2008, Pages 253-256

  Gomez Choco M ^a   Obach, V ^a   Urra, X ^a   Amaro, S ^a   Cervera, A ^a   Vargas, M ^a   Chamorro, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Age; Elderly; Gender; Sex; Stroke therapy; Thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT;

AGED; AGING; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; STROKE; STROKE PATIENT; SYMPTOMATOLOGY;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; GERIATRICS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 39149115713     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.02042.x     Document Type: Article

References (18)

1. Hacke W, Donnan G, Fieschi C, et al. ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004 363 : 768 774.
2. Tanne D, Gorman MJ, Bates VE, et al. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older. The tPA stroke Survey experience. Stroke 2000 31 : 370 375.
3. Berrouschot J, Röther J, Glahn J, Kucinski T, Fiehler J, Thomalla G. Outcome and severe hemorragic complications of intravenous thrombolysis with tissue plasminogen activator in very old (≥80 years) stroke patients. Stroke 2005 36 : 2421 2425.
4. Sylaja PN, Cote R, Buchar AM, Hill MD Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Thrombolysis in patients older than 80 years with acute ischemic stroke: Canadian Alteplase for Stroke Effectiveness Study. Journal of Neurology, Neurosurgery and Psychiatry 2006 77 : 826 829.
5. Oostenbrugge RJ, Huppert RMM, Lodder J. Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre. Journal of Neurology, Neurosurgery and Psychiatry 2006 77 : 375 377.
6. Engelter ST, Reichhart M, Sekoranja L, et al. Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology 2005 65 : 1795 1798.
7. Engelter ST, Bonati LH, Lyrer P. Intravenous trhombolysis in stroke patients of ≥80 versus <80 years of age-a systematic review across cohort studies. Age and Ageing 2006 35 : 572 580.
8. Holliday R. Ageing in the 21st century. Lancet 1999 354 Suppl : SIV4.
9. Saposnik G, Di Legge S, Webster F, Hachinski V. Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology 2005 65 : 1169 1174.
10. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke. A pooled analysis of randomised clinical trials. Stroke 2005 36 : 62 65.
11. Elkind MS, Prabhakaran S, Pittman J, et al. Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke. Neurology 2007 68 : 842 848.
12. Roof RL, Hall ED. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. Journal of Neurotrauma 2000 17 : 367 388.
13. Gebara OC, Mittleman MA, Sutherand P, et al. Association between increased estrogen status and increased fibrinolytic potential in the Framinghan Offspring study. Circulation 1995 91 : 1952 1958.
14. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine 1995 333 : 1581 1587.
15. Adams HP, Bendixen BH, Kappelle LJ, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Trial of Org 10172 in acute stroke treatment (TOAST). Stroke 1993 24 : 35 41.
16. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. The Lancet 2007 369 : 275 282.
17. Ringleb PA, Schwark Ch, Kohrmann M, et al. Thrombolytic therapy for acute ischemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome. Journal of Neurology, Neurosurgery and Psychiatry 2007 78 : 690 693.
18. Martí-Fábregas J, Bravo Y, Cocho D, et al. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials. Cerebrovascular Diseases 2007 23 : 85 90.